Alamar Biosciences Updates 2026 Revenue Guidance

Alamar Biosciences updated its full-year 2026 revenue guidance to $121 million–$123 million, above the FactSet consensus estimate of $118.6 million. The company said the outlook reflects its current business trajectory and market expectations for its proteomics platform.